Finance

Lists
T1CH34:BVMF
Bio Techne Corporation Bdr
R$12.42
0.00%
(0.00) 1D
Sep 4, 4:56:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for T1CH34...
Open
R$12.42
High
R$12.42
Low
R$12.42
Mkt. cap
11.36B
Avg. vol.
166.00
Volume
10.00
52-wk high
R$12.60
52-wk low
R$7.33
Shares outstanding
156.82M
No. of employees
3K
Open
R$12.42
High
R$12.42
Low
R$12.42
Mkt. cap
11.36B
Avg. vol.
166.00
Volume
10.00
52-wk high
R$12.60
52-wk low
R$7.33
Shares outstanding
156.82M
No. of employees
3K
Profile
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
About Bio Techne Corporation Bdr
CEOKim Kelderman
Employees3K
Founded1976
HeadquartersMinneapolis, Minnesota, United States
SectorHealth care
Websitebio-techne.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
286.56M
295.88M
311.42M
321.19M
Cost of goods sold
96.36M
102.69M
101.98M
109.14M
Cost of revenue
96.36M
102.69M
101.98M
109.14M
Research and development expenses
24.24M
23.12M
23.46M
23.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
117.57M
111.87M
107.54M
98.59M
Operating expense
141.81M
134.99M
130.99M
122.53M
Total operating expenses
238.18M
237.68M
232.97M
231.67M
Operating income
48.38M
58.20M
78.45M
89.52M
Other non operating income
2.00M
-2.51M
-2.11M
1.89M
EBT including unusual items
47.99M
50.78M
71.22M
70.68M
EBT excluding unusual items
48.71M
54.52M
74.18M
91.79M
Income tax expense
9.81M
12.78M
20.18M
16.06M
Effective tax rate
20.43%
25.16%
28.33%
22.72%
Other operating expenses
-
-
-
-
Net income
38.18M
38.01M
51.05M
54.62M
Net profit margin
13.33%
12.85%
16.39%
17.01%
Earnings per share
0.42
0.46
0.53
0.52
Interest and investment income
971.00K
897.00K
981.00K
1.37M
Interest expense
-2.93M
-2.17M
-2.40M
-2.12M
Net interest expenses
-1.96M
-1.27M
-1.42M
-750.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
72.72M
82.91M
102.62M
113.66M
Gain or loss from assets sale
-6.79M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps